PLUS THERAPEUTICS, INC. Balance Sheet
PSTV|10 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 10 fiscal years. All figures from audited SEC 10-K filings.
PLUS THERAPEUTICS, INC. had $16M in total assets with negative shareholders' equity of $9M as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.3M | $76.0K | $12.6M | $12.6M | $14.3M | $14.6M | $25.7M | $36.9M | $52.7M | $12.6M |
| Accounts Receivable | - | - | $145.0K | $145.0K | $1.2M | $1.1M | $1.2M | $4.2M | $3.9M | $2.1M |
| Inventory | - | - | $3.2M | $3.2M | $3.7M | $4.3M | $4.8M | $3.7M | $3.2M | $3.4M |
| Current Assets | $15.2M | $5.3M | $14.9M | $14.9M | $18.7M | $21.2M | $21.7M | $24.6M | $34.0M | $59.0M |
| PP&E (Net) | $257.0K | $448.0K | $3.1M | $3.1M | $1.2M | $1.6M | $1.6M | $1.1M | $2.2M | $1.7M |
| Goodwill | $372.0K | $372.0K | $3.9M | $3.9M | $3.9M | $3.9M | $3.9M | $3.9M | $3.9M | $3.9M |
| Total Assets | $16.3M | $6.6M | $31.6M | $31.6M | $34.6M | $37.7M | $38.7M | $42.1M | $43.3M | $66.3M |
| Current Liabilities | $12.3M | $15.6M | $18.4M | $18.4M | $12.5M | $8.4M | $15.9M | $14.9M | $17.6M | $13.2M |
| Shareholders' Equity | -$8.9M | -$1.3M | $11.0M | $11.0M | $12.2M | -$5.7M | $6.5M | $9.9M | $22.9M | -$7.7M |